Related Experiment Video
Updated: Jul 19, 2026
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Novel poly(ADP-ribose) polymerase-1 inhibitors
Derek Dunn1, Jean Husten, Mark A Ator
1Cephalon Inc., 145 Brandywine Parkway, West Chester, PA 19380-4245, USA.
Bioorganic & Medicinal Chemistry Letters
|November 1, 2006
Summary
Researchers synthesized novel pyrrolocarbazole analogs with thiazole substitutions, identifying potent poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. These compounds show promise for therapeutic applications targeting PARP-1 activity.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Enzyme Inhibition
Background:
- Poly(ADP-ribose) polymerase-1 (PARP-1) is a key enzyme involved in DNA repair.
- Dysregulation of PARP-1 is implicated in various diseases, including cancer.
- Developing selective PARP-1 inhibitors is a significant therapeutic goal.
Purpose of the Study:
- To synthesize and characterize novel pyrrolocarbazole analogs.
- To evaluate the inhibitory activity of these analogs against PARP-1.
- To explore the structure-activity relationships of 4-thiazol-yl substituted pyrrolocarbazoles.
Main Methods:
- Multi-step organic synthesis for analog preparation.
- Biochemical assays to determine PARP-1 inhibitory potency (e.g., IC50 values).
- Structure-activity relationship (SAR) analysis.
Main Results:
- A series of 4-thiazol-yl substituted pyrrolocarbazole analogs were successfully synthesized.
- Several analogs demonstrated significant poly(ADP-ribose) polymerase-1 (PARP-1) inhibitory activity.
- Structure-activity relationship studies provided insights into key pharmacophoric features.
Conclusions:
- The synthesized pyrrolocarbazole analogs represent a novel class of PARP-1 inhibitors.
- These compounds hold potential for further development as therapeutic agents.
- The study contributes to the ongoing search for effective PARP-1 targeted therapies.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...